Post-Stage 2 Palliation Single Ventricular Assist Device Outcomes: An Advanced Cardiac Therapies Improving Outcomes Network (Action) Registry Analysis

The safety profile was comparable between both units (adverse events per 10 patient days, SDU: 0.052 vs MDS: 0.021, p>0.05).None of the 4 serious adverse events were related to the MDU. Conclusion:This study shows that the novel mobile driving system is safe and effective for pVAD support in pediatric patients.The potential to increase patient mobility indicates an elevated QoL in this cohort.